Generate Biomedicines, Inc. (GENB)
17.71
+1.59
(+9.86%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.09
(-0.51%)
After-Hours: 20:00
Generate Biomedicines Market Cap : 2.272B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.068B |
| August 20, 2026 | 2.051B |
| August 19, 2026 | 2.177B |
| August 18, 2026 | 2.063B |
| August 17, 2026 | 2.013B |
| August 14, 2026 | 2.006B |
| August 13, 2026 | 1.928B |
| August 12, 2026 | 1.936B |
| August 11, 2026 | 1.830B |
| August 10, 2026 | 1.888B |
| August 07, 2026 | 1.841B |
| August 06, 2026 | 1.782B |
| August 05, 2026 | 1.859B |
| August 04, 2026 | 1.832B |
| August 03, 2026 | 1.838B |
| July 31, 2026 | 1.795B |
| July 30, 2026 | 1.799B |
| July 29, 2026 | 1.677B |
| July 28, 2026 | 1.684B |
| July 27, 2026 | 1.754B |
| July 24, 2026 | 1.718B |
| July 23, 2026 | 1.773B |
| July 22, 2026 | 1.782B |
| July 21, 2026 | 1.845B |
| July 20, 2026 | 1.741B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.738B |
| July 16, 2026 | 1.751B |
| July 15, 2026 | 1.804B |
| July 14, 2026 | 1.822B |
| July 13, 2026 | 1.831B |
| July 10, 2026 | 1.836B |
| July 09, 2026 | 2.015B |
| July 08, 2026 | 2.034B |
| July 07, 2026 | 2.079B |
| July 06, 2026 | 2.169B |
| July 02, 2026 | 2.232B |
| July 01, 2026 | 2.115B |
| June 30, 2026 | 2.163B |
| June 29, 2026 | 2.168B |
| June 26, 2026 | 2.111B |
| June 25, 2026 | 2.105B |
| June 24, 2026 | 2.081B |
| June 23, 2026 | 1.978B |
| June 22, 2026 | 2.037B |
| June 18, 2026 | 1.858B |
| June 17, 2026 | 1.778B |
| June 16, 2026 | 1.714B |
| June 15, 2026 | 1.741B |
| June 12, 2026 | 1.587B |
| June 11, 2026 | 1.658B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 8.821B |
| Prime Medicine, Inc. | 588.30M |
| Intellia Therapeutics, Inc. | 1.757B |
| Beam Therapeutics, Inc. | 2.927B |
| Moderna, Inc. | 55.39B |
Market Cap Related Metrics
| PS Ratio | 43.95 |
| Price to Book Value | 4.981 |
| Price | 17.71 |
| Earnings Yield | -26.08% |